News from Zentiva

March 25, 2021    /    Press Releases

Production Record for Zentiva’s Prague Site

MAXIMISING THE SUPPLY OF MEDICINES IS MORE IMPORTANT THAN EVER, AS ZENTIVA RESPONDS TO PATIENT NEEDS ACROSS EUROPE

 

PRAGUE – March 25, 2021: Zentiva, the largest manufacturer of medicines in the Czech Republic, produced 129 million  of medicines in 2020. This is an all-time-high since founding the site more than 90 years ago. 

“We are united in our ambition to maximize our output and to ensure the supply of high-quality and affordable medicines to the people that rely on our products every day. We are conscious of the responsibility we have and we are joining forces with healthcare professionals, pharmacists, and health system decision-makers to fight against COVID-19 and navigate the crisis. As a company we acted fast and flexibly, adapted and increased our production activity, and created a safe environment for our people who have to come to our Zentiva campus to keep Development and Production activities ongoing”, says Denis Paris, Head of Prague Site.

Zentiva’s Prague Site produces tablets, hospital injectables medicines, ointments, hormones, eye drops, and suspensions. It is now the 3rd year in a row that Zentiva Prague increased its production capacity. 1 out of 5 prescribed products in the Czech Republic produced by Zentiva. The site is producing medicines used in intensive care units, life-saving medicines and a wide portfolio that help patients with chronic and acute conditions. During the first phase of the COVID-pandemic, SANICOR, a disinfection solution and spray was also added to the portfolio to help reduce virus transfer on the hands and surfaces. 

Denis Paris: “We had to significantly change the way we operate. Thanks to the engagement and the trust of our people we could make it happen and today we are stronger than ever. There is a high commitment of the company to further invest into our home country, where we employ 1.500 people working in Development, our Manufacturing Site, our Commercial Organization and at our Headquarters.

Zentiva’s roots reach back 530 years to the Black Eagle pharmacy, a small business that served the people of Prague. We are very proud that the heart of business is in the Czech Republic and have a strong investment programme underway allowing for further expansion and the creation of new employment opportunities.

 


About Zentiva

Zentiva is a producer of high-quality affordable medicines serving patients in Europe and beyond. With a dedicated team of more than 4,500 people and a network of production sites - including flagship sites in Prague, Bucharest, and Ankleshwar - Zentiva strives to be the champion of branded and generic medicines in Europe to better support people’s daily healthcare needs.
At Zentiva it is our aspiration that healthcare should be a right and not a privilege. More than ever, people need better access to high-quality affordable medicines and healthcare. We work in partnership with physicians, pharmacists, wholesalers, regulators, and governments to provide the everyday solutions that we all depend on. Learn more about Zentiva.com 

Media Contact

Mounira Lemoui
Head of Communications
ZENTIVA GROUP, a.s.
U kabelovny 529/16, Dolní Měcholupy, 102 00 Prague 10
Mobil: (+420) 727 873 159
E-mail:
mounira.lemoui@zentiva.com